EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Assessment of Skin Autofluorescence and Its Association with Glycated Hemoglobin, Cardiovascular Risk Markers, and Concomitant Chronic Diseases in Children with Type 1 Diabetes

Marta Jankowska, Agnieszka Szadkowska, Iwona Pietrzak, Jędrzej Chrzanowski, Julia Sołek, Wojciech Fendler, Beata Mianowska iD

Nutrients · 2024

DOI: 10.3390/nu16121940 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nutrients, 2024. Verfasst von Marta Jankowska und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Diabetology, Endocrinology and Nephrology, Medical University of Lodz, 91-738 Lodz, Poland. Hauptthemen laut MEDLINE: Glycated Hemoglobin, Diabetes Mellitus, Type 1, Skin, Glycation End Products, Advanced. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Skin autofluorescence (sAF) measurement is a non-invasive method used to assess tissue advanced glycation end product (AGE) accumulation. This study aims to characterize sAF’s association with (1) glycated hemoglobin (HbA1c) values, (2) cardiovascular risk markers, and (3) common comorbidities (autoimmune thyroiditis, celiac disease) in children with type 1 diabetes (T1D). Materials and methods: A total of 348 children with T1D aged 3–18 years and 85 age- and gender-matched control subjects were enrolled. sAF was quantified using an AGE Reader (Diagnoptics BV, The Netherlands). The analysis covered HbA1c, blood lipid, and C-reactive protein (CRP) levels, ambulatory blood pressure monitoring records, and body composition parameters. The associations between variables and sAF were assessed using the Mann–Whitney U test and Spearman correlation.

Results

We observed significantly higher sAF values in the T1D group compared to the control (1.40 [1.27–1.53] vs. 1.20 [1.07–1.30, AU]; p = 0.004), consistent across all tested age groups. In the T1D group, sAF was positively correlated with current HbA1c, mean of historical HbA1c values, and T1D duration (r values, respectively: 0.27, 0.22, 0.14, all p < 0.01). Percentage of body fat was positively correlated with sAF (r = 0.120; p = 0.044). No significant correlations were found between sAF and lipid fractions, Z-score of BMI, parameters from 24 h ambulatory blood pressure monitoring, or the amount of albumin excreted in urine. sAF was positively correlated with CRP (r = 0.17, p < 0.05). sAF was significantly higher in patients with concomitant celiac disease (1.53 [1.43–1.63] vs. 1.40 [1.27–1.53, AU], p = 0.001).

Conclusion

Among young T1D patients with relatively brief diabetes duration, sAF effectively mirrors prior glycemic control, as presented by historical average HbA1c. However, associations with conventional CV risk markers are not evident. The higher sAF values in patients with celiac disease warrant further exploration.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Glycated HemoglobinDiabetes Mellitus, Type 1SkinGlycation End Products, AdvancedHeart Disease Risk FactorsHumansChildFemaleMaleAdolescentChild, PreschoolBiomarkersCardiovascular DiseasesChronic DiseaseOptical ImagingC-Reactive ProteinCase-Control StudiesCeliac DiseaseComorbidity

Stichwörter der Autor:innen

HbA1cadvanced glycation end productsbody fatcardiovascular riskceliac diseasechildrendiabetes complicationsskin autofluorescencetype 1 diabetes

Substanzen

Glycated HemoglobinGlycation End Products, AdvancedBiomarkershemoglobin A1c protein, humanC-Reactive Protein

Autor:innen und Institutionen

  • Department of Pediatrics, Diabetology, Endocrinology and Nephrology, Medical University of Lodz, 91-738 Lodz, Poland.
  • Department of Developmental Neurology and Epileptology, Polish Mother's Memorial Hospital-Research Institute, 93-338 Lodz, Poland.
  • Department of Biostatistics and Translational Medicine, Medical University of Lodz, 92-215 Lodz, Poland.
  • Department of Pathology, Chair of Oncology, Medical University of Lodz, 92-213 Lodz, Poland.

ORCID-Profile: Beata Mianowska

Zitieren

APA

Jankowska, M., Szadkowska, A., Pietrzak, I., Chrzanowski, J., Sołek, J., Fendler, W., & Mianowska, B. (2024). Assessment of Skin Autofluorescence and Its Association with Glycated Hemoglobin, Cardiovascular Risk Markers, and Concomitant Chronic Diseases in Children with Type 1 Diabetes. Nutrients. https://doi.org/10.3390/nu16121940

Vancouver

Jankowska M, Szadkowska A, Pietrzak I, Chrzanowski J, Sołek J, Fendler W, et al. Assessment of Skin Autofluorescence and Its Association with Glycated Hemoglobin, Cardiovascular Risk Markers, and Concomitant Chronic Diseases in Children with Type 1 Diabetes. Nutrients. 2024. doi:10.3390/nu16121940

BibTeX
@article{Jankowska2024,
  author = {Jankowska, Marta and Szadkowska, Agnieszka and Pietrzak, Iwona and Chrzanowski, Jędrzej and Sołek, Julia and Fendler, Wojciech and Mianowska, Beata},
  title = {Assessment of Skin Autofluorescence and Its Association with Glycated Hemoglobin, Cardiovascular Risk Markers, and Concomitant Chronic Diseases in Children with Type 1 Diabetes},
  journal = {Nutrients},
  year = {2024},
  doi = {10.3390/nu16121940}
}
Kostenlos starten →